GS0421: Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies
Case File Event Statements
5/13/2011 - 13 years ago
24 - CANCELLED SEC. 8 (6-YR)Type:C8..
10/12/2004 - 20 years ago
23 - REGISTERED-PRINCIPAL REGISTERType:R.PR
8/16/2004 - 20 years ago
22 - LAW OFFICE REGISTRATION REVIEW COMPLETEDType:REGV
8/3/2004 - 20 years ago
21 - ASSIGNED TO LIEType:ALIE
7/28/2004 - 20 years ago
20 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
7/28/2004 - 20 years ago
19 - ASSIGNED TO EXAMINERType:DOCK
7/26/2004 - 20 years ago
18 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
1/15/2004 - 21 years ago
17 - USE AMENDMENT FILEDType:IUAF
7/26/2004 - 20 years ago
16 - EXTENSION 1 GRANTEDType:EX1G
1/13/2004 - 21 years ago
15 - EXTENSION 1 FILEDType:EXT1
7/9/2004 - 20 years ago
14 - FAX SENTType:FAXX
5/24/2004 - 20 years ago
13 - CASE FILE IN TICRSType:CFIT
1/15/2004 - 21 years ago
12 - PAPER RECEIVEDType:MAIL
1/13/2004 - 21 years ago
11 - FAX RECEIVEDType:FAXX
7/15/2003 - 21 years ago
10 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
4/22/2003 - 21 years ago
9 - PUBLISHED FOR OPPOSITIONType:PUBO
4/2/2003 - 21 years ago
8 - NOTICE OF PUBLICATIONType:NPUB
12/12/2002 - 22 years ago
7 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/6/2002 - 22 years ago
6 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
6/10/2002 - 22 years ago
5 - FINAL REFUSAL MAILEDType:CNFR
4/30/2002 - 22 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA